These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 29099271)
1. SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell. Feng C; Ma F; Hu C; Ma JA; Wang J; Zhang Y; Wu F; Hou T; Jiang S; Wang Y; Feng Y Cell Cycle; 2018; 17(4):448-458. PubMed ID: 29099271 [TBL] [Abstract][Full Text] [Related]
2. MiR-34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin-based chemotherapy. Xiao S; Li Y; Pan Q; Ye M; He S; Tian Q; Xue M J Cell Biochem; 2019 Mar; 120(3):2940-2953. PubMed ID: 30537410 [TBL] [Abstract][Full Text] [Related]
3. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells. Li N; Yang L; Wang H; Yi T; Jia X; Chen C; Xu P PLoS One; 2015; 10(6):e0128886. PubMed ID: 26043084 [TBL] [Abstract][Full Text] [Related]
4. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin. Feng Y; Zou W; Hu C; Li G; Zhou S; He Y; Ma F; Deng C; Sun L Arch Biochem Biophys; 2017 Jun; 623-624():20-30. PubMed ID: 28495512 [TBL] [Abstract][Full Text] [Related]
5. Chi C; Mao M; Shen Z; Chen Y; Chen J; Hou W Hum Gene Ther; 2018 Dec; 29(12):1438-1448. PubMed ID: 29896986 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-215-3p suppresses the growth and metastasis of cervical cancer cell via targeting SOX9. Liu CQ; Chen Y; Xie BF; Li YL; Wei YT; Wang F Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5628-5639. PubMed ID: 31298315 [TBL] [Abstract][Full Text] [Related]
7. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4. Hu B; Zhang H; Wang Z; Zhang F; Wei H; Li L Cancer Biol Ther; 2017 Dec; 18(12):974-983. PubMed ID: 29020498 [TBL] [Abstract][Full Text] [Related]
8. MiR-203 regulates DJ-1 expression and affects proliferation, apoptosis and DDP resistance of pancreatic cancer cells. Du SL; Xu LY; Gao P; Liu QS; Lu FF; Mo ZH; Fan ZZ; Cheng XL; Dong ZH Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8833-8840. PubMed ID: 31696470 [TBL] [Abstract][Full Text] [Related]
9. [Regulatory effects and associated mechanisms of miR-130a molecules on cisplatin resistance in ovarian cancer A2780 cell lines]. Li NW; Wang HJ; Yang LY; Jia XB; Chen C; Wang X Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):865-70. PubMed ID: 24490491 [TBL] [Abstract][Full Text] [Related]
10. microRNA-130a Promotes Human Keratinocyte Viability and Migration and Inhibits Apoptosis Through Direct Regulation of STK40-Mediated NF-κB Pathway and Indirect Regulation of SOX9-Meditated JNK/MAPK Pathway: A Potential Role in Psoriasis. Xiong Y; Chen H; Liu L; Lu L; Wang Z; Tian F; Zhao Y DNA Cell Biol; 2017 Mar; 36(3):219-226. PubMed ID: 28085489 [TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog. Feng Y; Zhou S; Li G; Hu C; Zou W; Zhang H; Sun L Arch Biochem Biophys; 2016 May; 598():57-65. PubMed ID: 27040383 [TBL] [Abstract][Full Text] [Related]
12. NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells. Jiang P; Wu X; Wang X; Huang W; Feng Q Oncotarget; 2016 Jul; 7(28):43337-43351. PubMed ID: 27270317 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Zhang X; Huang L; Zhao Y; Tan W Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606 [TBL] [Abstract][Full Text] [Related]
14. LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling. Chen J; Li Y; Li Z; Cao L J Biochem Mol Toxicol; 2020 Apr; 34(4):e22452. PubMed ID: 32052927 [TBL] [Abstract][Full Text] [Related]
15. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells. Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472 [No Abstract] [Full Text] [Related]
16. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis. Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9. Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941 [TBL] [Abstract][Full Text] [Related]
18. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Cao L; Chen J; Ou B; Liu C; Zou Y; Chen Q Biomed Pharmacother; 2017 Sep; 93():570-579. PubMed ID: 28686971 [TBL] [Abstract][Full Text] [Related]
19. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112 [TBL] [Abstract][Full Text] [Related]
20. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD. Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]